These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 19714336)

  • 1. Prognostic value of microvessel density in prostate cancer: a tissue microarray study.
    Erbersdobler A; Isbarn H; Dix K; Steiner I; Schlomm T; Mirlacher M; Sauter G; Haese A
    World J Urol; 2010 Dec; 28(6):687-92. PubMed ID: 19714336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological significance and prognostic role of microvessel density, evaluated using CD31, CD34, and CD105 in prostate cancer patients after radical prostatectomy with neoadjuvant therapy.
    Miyata Y; Mitsunari K; Asai A; Takehara K; Mochizuki Y; Sakai H
    Prostate; 2015 Jan; 75(1):84-91. PubMed ID: 25307287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.
    Rubin MA; Buyyounouski M; Bagiella E; Sharir S; Neugut A; Benson M; de la Taille A; Katz AE; Olsson CA; Ennis RD
    Urology; 1999 Mar; 53(3):542-7. PubMed ID: 10096381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvessel density as a predictor of PSA recurrence after radical prostatectomy. A comparison of CD34 and CD31.
    de la Taille A; Katz AE; Bagiella E; Buttyan R; Sharir S; Olsson CA; Burchardt T; Ennis RD; Rubin MA
    Am J Clin Pathol; 2000 Apr; 113(4):555-62. PubMed ID: 10761458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate.
    Silberman MA; Partin AW; Veltri RW; Epstein JI
    Cancer; 1997 Feb; 79(4):772-9. PubMed ID: 9024715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy.
    Bettencourt MC; Bauer JJ; Sesterhenn IA; Connelly RR; Moul JW
    J Urol; 1998 Aug; 160(2):459-65. PubMed ID: 9679898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvessel density in prostate carcinoma.
    Bono AV; Celato N; Cova V; Salvadore M; Chinetti S; Novario R
    Prostate Cancer Prostatic Dis; 2002; 5(2):123-7. PubMed ID: 12497001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer.
    Strohmeyer D; Rössing C; Strauss F; Bauerfeind A; Kaufmann O; Loening S
    Prostate; 2000 Jan; 42(1):26-33. PubMed ID: 10579796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens?
    Schlemmer HP; Merkle J; Grobholz R; Jaeger T; Michel MS; Werner A; Rabe J; van Kaick G
    Eur Radiol; 2004 Feb; 14(2):309-17. PubMed ID: 14531000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.
    Ekici S; Cerwinka WH; Duncan R; Gomez P; Civantos F; Soloway MS; Lokeshwar VB
    Int J Cancer; 2004 Oct; 112(1):121-9. PubMed ID: 15305383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent prognostic importance of microvessel density in clinically localized prostate cancer.
    Halvorsen OJ; Haukaas S; Høisaeter PA; Akslen LA
    Anticancer Res; 2000; 20(5C):3791-9. PubMed ID: 11268456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate.
    Krupski T; Petroni GR; Frierson HF; Theodorescu JU
    Urology; 2000 May; 55(5):743-9. PubMed ID: 10792093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays.
    Tretiakova M; Antic T; Binder D; Kocherginsky M; Liao C; Taxy JB; Oto A
    Hum Pathol; 2013 Apr; 44(4):495-502. PubMed ID: 23069258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease.
    Di Lorenzo G; De Placido S; Autorino R; De Laurentiis M; Mignogna C; D'Armiento M; Tortora G; De Rosa G; D'Armiento M; De Sio M; Bianco AR; D'Armiento FP
    Prostate Cancer Prostatic Dis; 2005; 8(1):54-9. PubMed ID: 15655565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of androgen receptor status, neuroendocrine differentiation and angiogenesis with time-to-biochemical failure after radical prostatectomy in clinically localized prostate cancer.
    Revelos K; Petraki C; Scorilas A; Stefanakis S; Malovrouvas D; Alevizopoulos N; Kanellis G; Halapas A; Koutsilieris M
    Anticancer Res; 2007; 27(5B):3651-60. PubMed ID: 17972531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic significance of vasohibin-1 expression in patients with prostate cancer.
    Kosaka T; Miyazaki Y; Miyajima A; Mikami S; Hayashi Y; Tanaka N; Nagata H; Kikuchi E; Nakagawa K; Okada Y; Sato Y; Oya M
    Br J Cancer; 2013 May; 108(10):2123-9. PubMed ID: 23591203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
    Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
    Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrences in stage II rectal carcinoma after curative resection alone: from the viewpoint of angiogenesis.
    Martinović Ž; Kovač D; Martinović C
    World J Surg Oncol; 2016 Apr; 14():122. PubMed ID: 27102733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical determination of tumor angiogenesis measured by the maximal microvessel density in human prostate cancer.
    Offersen BV; Borre M; Overgaard J
    APMIS; 1998 Apr; 106(4):463-9. PubMed ID: 9637268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.